Andina Capital Management LLC Takes $513,000 Position in Option Care Health, Inc. $OPCH

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Andina Capital Management LLC acquired a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 14,685 shares of the company's stock, valued at approximately $513,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Fuller & Thaler Asset Management Inc. boosted its holdings in Option Care Health by 30.8% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company's stock worth $146,947,000 after purchasing an additional 989,048 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Option Care Health by 17.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after purchasing an additional 591,042 shares during the last quarter. Northern Trust Corp boosted its holdings in Option Care Health by 11.8% during the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock worth $60,934,000 after purchasing an additional 278,158 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Option Care Health by 4.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company's stock worth $91,209,000 after purchasing an additional 99,574 shares during the last quarter. Finally, Nuveen LLC purchased a new position in Option Care Health during the first quarter worth about $70,965,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Option Care Health

In other Option Care Health news, Director Timothy P. Sullivan purchased 20,000 shares of the stock in a transaction dated Thursday, August 21st. The shares were bought at an average price of $27.51 per share, with a total value of $550,200.00. Following the completion of the transaction, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the stock in a transaction dated Wednesday, August 20th. The stock was acquired at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the transaction, the director owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.64% of the company's stock.

Option Care Health Stock Performance

OPCH stock traded up $0.90 during mid-day trading on Friday, hitting $28.74. The company had a trading volume of 2,369,675 shares, compared to its average volume of 1,997,394. The firm has a market cap of $4.66 billion, a PE ratio of 22.99, a price-to-earnings-growth ratio of 1.75 and a beta of 0.79. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The stock's fifty day moving average price is $29.92 and its two-hundred day moving average price is $31.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.40 by $0.01. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company's revenue for the quarter was up 15.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on OPCH shares. Citigroup restated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Barrington Research restated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a report on Thursday, July 10th. JMP Securities boosted their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a report on Thursday, July 31st. Finally, UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Eight research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, Option Care Health currently has an average rating of "Moderate Buy" and an average price target of $35.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.